Document:USA 21 CFR Part 809 06-May-2024: Difference between revisions
From GxPlex
Gxplex admin (talk | contribs) m 1 revision imported |
Migrate to Template:DocumentData for PageForms (GxPlexBot) |
||
| Line 1: | Line 1: | ||
{{DocumentData | |||
|reference=USA 21 CFR Part 809 06-May-2024 | |reference=USA 21 CFR Part 809 06-May-2024 | ||
|validity_area=USA | |validity_area=USA | ||
Revision as of 12:54, 16 July 2026
| Document information | |
|---|---|
| Reference | USA 21 CFR Part 809 06-May-2024 |
| Validity area | USA |
| Scope(s) | G |
| Document name | 21 CFR Part 809 |
| Version / Revision | 06-May-2024 |
| Status | Current |
| Document type | Legal act |
| Language(s) | EN |
| Description | |
| Official source | — |
| Restricted access | No |
| Submitted by | Florian Adragna |
| Contributors | |
References
| Scope | Document part | Language | Preview | |
|---|---|---|---|---|
| USA 21 CFR Part 809 06-May-2024 § 809.3 (a) | G | § 809.3 (a) | EN | § 809.3 Definitions. (a) In vitro diagnostic products are those reagents, instruments, and systems intended for use in the diagnosis of disease or o… |
References
| Reference | Scope | Document part | Language | Preview |
|---|---|---|---|---|
| Reference:USA 21 CFR Part 809 06-May-2024 § 809.3 (a) | G | § 809.3
(a) || EN || § 809.3 Definitions. (a) In vitro diagnostic products are those reagents, instruments, and systems intended for use in the diagnosis of disease or other conditions, including a determination of the ... |
